6 patents
Utility
Cancer Treatment Using FGFR Inhibitors and PLK1 Inhibitors
20 Apr 23
Provided include methods, compositions and kits for treating cancer in a subject.
Maya Ridinger, Mark Erlander, Anju Karki
Filed: 14 Oct 22
Utility
Treatment of Leukemias and Lymphomas with Combinations of BCL-2 Inhibitors and PLK1 Inhibitors
13 Apr 23
Provided include methods, compositions and kits for treating a leukemia or lymphoma in a subject.
Maya RIDINGER, Mark ERLANDER
Filed: 29 Jan 21
Utility
PLK1 Inhibitors and Psa Levels In Prostate Cancer
16 Jun 22
Mark Erlander, Thomas H. Adams, Maya Ridinger
Filed: 25 Mar 20
Utility
Onvansertib for Inhibiting Non-adrenergic Contraction of Smooth Muscle and Prostate Cell Proliferation
12 May 22
Provided is a method of treating benign prostatic hyperplasia (BPH) in a patient.
Mark Erlander, Maya Ridinger, Thomas H. Adams
Filed: 25 Feb 20
Utility
Selection and Treatment of Cancer with Combination Therapies
28 Apr 22
Certain molecular characteristics of cancer cells or tumors can be indicative of their sensitivity to various combination therapies.
Michael B. Yaffe, Jesse C. Patterson, Mark Erlander, Peter J.P. Croucher, Maya Ridinger
Filed: 27 Aug 21
Utility
PLK1 Target Phosphorylation Status and Treatment of Cancer with PLK1 Inhibitors
22 Jul 21
Maya Ridinger, Thomas H. Adams, Mark Erlander
Filed: 24 Aug 19
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first